KRAS and colorectal carcinoma: El-Deiry et al. determined KRAS status from 2510 primary CRC and 30 BM from CRC and found significantly higher rates of KRAS mutation in BM (65%) compared to the primary tumor (45%), but the samples were not paired [13].